๐ #ISLAA2026 โ WRAPPED. 8 sessions. 11 live cases. 3 continents. Founders' Lecture. Novel pipeline. DRT masterclass. Factor XIa debate. Edge cases that stay with you. Two days that advanced the global standard of LAOO care. See you at #ISLAA2027. ๐ซ #LAOO#EP#AFib#LAAClosure
๐ฌ Dr. Himanshu Agarwal at #ISLAA2026: TAVR + LAOOโstaged vs. concomitant, femoral access sharing, contrast load, dual anticoagulation obligations. An increasingly common combination in the ageing structural heart disease-AFib population. ๐ซ#TAVR#LAOO#StructuralHeartDisease
โ ๏ธ Dr. Lakkireddy at #ISLAA2026: Pseudo-embolization from TTE parallax error. Device was fine โ image said otherwise. TEE/CT confirmation before escalation for suspected embolisation: non-negotiable. TTE alone is insufficient. Full stop. ๐ซ#PseudoEmbolization#ParallaxError
๐ฌ Rare case at #ISLAA2026: Dr. Gopinathannairโintramural atrial thrombus after LAOO. Within the atrial wall. TEE and CT may miss it entirely. Challenges our follow-up protocols and our understanding of post-LAOO thrombosis. ๐ซ#IntramularThrombus#LAOO#RareCases#PostLAAO#EP
๐ฅ Boldest question at #ISLAA2026: Will Factor XIa inhibitors make LAOO redundant? Abelacimab, asundexian, milvexian โ OAC efficacy, minimal bleeding. If haemorrhage is solved, is the mechanical case over?
#FactorXIa#LAOO#AFib#StrokePrevention
๐ฅ Boldest question at #ISLAA2026: Will Factor XIa inhibitors make LAOO redundant? Abelacimab, asundexian, milvexian โ OAC efficacy, minimal bleeding. If haemorrhage is solved, is the mechanical case over? #FactorXIa#LAOO#AFib#StrokePrevention
๐ง Dr. Edip Gurol at #ISLAA2026: Brain MRI microbleeds (SWI), white matter hyperintensities (FLAIR), cortical siderosisโneuroimaging biomarkers tipping OAC vs LAOO decision. The patient with microbleeds=your clearest LAOO indication. Practice-changing. #BrainImaging#MRI
๐ก Dr. Jalag Garg at #ISLAA2026: DCCV after LAOO โ imaging requirements (TEE alone? CT?), timepoint post-implant, OAC bridging, and management when DRT is found at pre-DCCV workup. Guideline gaps with real consequences. ๐ซ #DCCV#LAOO#PostLAAO#OAC#TEE#EP
๐ก Session 15 LIVE at #ISLAA2026: AF & Stroke โ substrate, APT, OAC, and the expanding toolkit. LAOO, NOACs, Factor XIa inhibitors, ablation โ how do they integrate intelligently in 2026? ๐ซ #AFib#StrokePrevention#OAC#APT#LAOO#EP
๐ฌ Session 14 Panel at #ISLAA2026 โ DRT definition to aspiration: the most complete clinical DRT framework outside a formal guideline. Know it. Use it. ๐ซ #DRT#LAOO#EP
๐ฌ Dr. Andrea Natale at #ISLAA2026: Device design and DRT-fabric chemistry, face geometry (flat/concave/convex), strut exposure, dual-seal vs. single-plug endothelialisation differences. DRT rate variation between platforms is mechanistically explainable. Design IS the lever.
๐ฅ Case in the Box at #ISLAA2026: Dr. Andrea Natale - Flowrunner catheter DRT aspiration! Pharmacology failed โ mechanical aspiration over the device face. Targeted, precise, thrombolytic-free. Compelling option for large/mobile DRT. #DRT#Flowrunner#DRTAspiration#LAOO#EP